CD44variant exon 9 plays an important role in colon cancer initiating cells

Oncotarget

Volumn 4, Issue 5, 2013, Pages 785-791

  Kimura, Youhei ^a   Goi, Takanori ^a   Nakazawa, Toshiyuki ^a   Hirono, Yasuo ^a   Katayama, Kanji ^a   Urano, Takeshi ^b   Yamaguchi, Akio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Cancer initiating cells; CD44 variant exon; Colon cancer; Stem cells

Indexed keywords

CANCER ANTIBODY; CD44V9 ANTIBODY; FLUOROURACIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CD44 VARIANT 9 GENE; CELL SEPARATION; COLON CANCER; COLON MUCOSA; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EXON; FEMALE; FLOW CYTOMETRY; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INTESTINE CRYPT; MARKER GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84880256689     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1048     Document Type: Article

References (28)

1. Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, et al. Japanese Society for Cancer of the Colon and Rectum: Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17: 1-29.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, and Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127: 2893-2917.
3. NCCN Clinical Practice Guidelines in Oncology. Antiemesis.V.2.2010. Available from: URL: http://www. nccn.org/professionals/physician-gls/PDF/antiemesis.
4. Ricci-Vitiani L, Fabrizi E, Palio E, De Maria R. Colon cancer stem cells. J Mol Med. 2009; 87: 1097-1104.
5. Alison MR, Islam S, Wright NA. Stem cells in cancer: instigators and propagators?. J Cell Sci. 2010; 123: 2357-2368.
6. Dean M, Fojo T, Bates S.Tumour stem cells and drug resistance. Nature Reviews. 2005; 5: 275-284.
7. Ailles LE, Weissman IL.Cancer stem cells in solid tumors. Curr Opin Biotechnol. 2007; 18: 460-466.
8. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444: 756-760.
9. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, , Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367: 645-648.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100: 3983-3988.
11. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature. 2004; 432: 396-401.
12. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445: 106-110.
13. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells.Nature. 2007; 445: 111-115.
14. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991; 10: 343-348.
15. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.Cancer Res. 1991; 51: 5292-5297.
16. Guo YJ, Liu G, Wang X, Jin D, Wu M, Ma J, Sy MS. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994; 54: 422-426.
17. Goi T, Yamaguchi A, Takeuchi K, Nakagawara G, Yamashiro S, Furukawa K, Urano T, Shiku H. CD44 with variant exons 8-10 in colorectal tumors:expression analysis by a variant exon 9-specific monoclonal antibody. Int J Oncol. 1996; 8: 657-662.
18. Yamaguchi A, Goi T, Yu J, Hirono Y, Ishida M, Iida A, Kimura T, Takeuchi K, Katayama K, Hirose K. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis. J Surg Oncol. 2002; 79: 230-235.
19. Jang BI, Li Y, Graham DY, Cen P. The role of CD44 in the pathogenesis, diagnosis, and therapy of gastric cancer. Gut Liver. 2011; 3: 397-405.
20. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458: 780-783.
21. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth.Cancer Cell. 2011; 19: 387-400.
22. Goi T, Yamaguchi A, Nakagawara G, Urano T, Shiku H, Furukawa K. Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. Br J Cancer. 1998; 77: 466-471.
23. Aso K, Goi T, Nakazawa T, Kimura Y, Hirono Y, Katayama K, Yamaguchi A. The expression of integrins is decreased in colon cancer cells treated with polysaccharide K. Int J Oncol. 2013; 42: 1175-1180.
24. Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor.Cancer Res. 2004 ; 64: 1906-1910.
25. ClarkMF, Dick JE, Dirks PB, EavesCJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells-Perspectives on Current Statusand Future Directions:AACR Workshop on cancer stem cells. Cancer Res. 2006; 66: 9339-9344.
26. Dick JE. Stem cell concepts renew cancer research. Blood. 2008; 112: 4793-4807.
27. Becker AJ, Mcculloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963; 197: 452-454.
28. Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?" Nature Reviews Cancer. 2011; 11, 254-267.